Avanos Medical Ownership
| AVNS Stock | USD 11.83 0.44 3.86% |
Shares in Circulation | First Issued 2013-03-31 | Previous Quarter 46 M | Current Value 46.8 M | Avarage Shares Outstanding 47.1 M | Quarterly Volatility 678.9 K |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avanos Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. Avanos Stock Ownership Analysis
About 96.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.63. Some equities with similar Price to Book (P/B) outperform the market in the long run. Avanos Medical has Price/Earnings To Growth (PEG) ratio of 2.29. The entity recorded a loss per share of 8.27. The firm had not issued any dividends in recent years. Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia. Avanos Medical operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 4555 people. For more info on Avanos Medical please contact Joseph Woody at 844 428 2667 or go to https://avanos.com.Besides selling stocks to institutional investors, Avanos Medical also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Avanos Medical's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Avanos Medical's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Avanos Medical Quarterly Liabilities And Stockholders Equity |
|
Avanos Medical Insider Trades History
Roughly 4.0% of Avanos Medical are currently held by insiders. Unlike Avanos Medical's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Avanos Medical's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Avanos Medical's insider trades
Avanos Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Avanos Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Avanos Medical backward and forwards among themselves. Avanos Medical's institutional investor refers to the entity that pools money to purchase Avanos Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Tributary Capital Management, Llc | 2025-03-31 | 737.2 K | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 685.8 K | Charles Schwab Investment Management Inc | 2025-03-31 | 608.6 K | Millennium Management Llc | 2025-03-31 | 547.7 K | Northern Trust Corp | 2025-03-31 | 505.2 K | Clark Estates Inc | 2025-03-31 | 493.9 K | Qube Research & Technologies | 2025-03-31 | 471.9 K | Ing Investment Management Llc | 2025-03-31 | 431.4 K | Pacer Advisors, Inc. | 2025-03-31 | 422.6 K | Blackrock Inc | 2025-03-31 | 6.9 M | Vanguard Group Inc | 2025-03-31 | 5.3 M |
Avanos Medical Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Avanos Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Avanos Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Avanos Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Pacitti David 2 days ago Insider Trading | ||
Pacitti David few days ago Insider Trading | ||
Pacitti David few days ago Insider Trading | ||
Pacitti David over a week ago Insider Trading | ||
Pacitti David over a week ago Insider Trading | ||
Pacitti David over a week ago Insider Trading | ||
Pacitti David over a week ago Insider Trading | ||
Pacitti David over a week ago Insider Trading | ||
Pacitti David over three weeks ago Insider Trading | ||
Pacitti David over three weeks ago Insider Trading | ||
Pacitti David over three weeks ago Insider Trading | ||
Pacitti David over three weeks ago Insider Trading |
Avanos Medical Outstanding Bonds
Avanos Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Avanos Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Avanos bonds can be classified according to their maturity, which is the date when Avanos Medical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US05352TAB52 Corp BondUS05352TAB52 | View | |
| AVANTOR FDG INC Corp BondUS05352TAA79 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| AVATION CAP S Corp BondUS05351CAA53 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| AVANGRID INC Corp BondUS05351WAB90 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Avanos Medical Corporate Filings
| 18th of June 2025 Other Reports | ViewVerify | |
| 2nd of June 2025 Other Reports | ViewVerify | |
| 14th of May 2025 Other Reports | ViewVerify | |
8K | 6th of May 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Avanos Stock Analysis
When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.